These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2432287)

  • 1. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor.
    Carey JT; Lederman MM; Toossi Z; Edmonds K; Hodder S; Calabrese LH; Proffitt MR; Johnson CE; Ellner JJ
    JAMA; 1987 Feb; 257(5):651-5. PubMed ID: 2432287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction.
    Alcocer-Varela J; Alarcon-Segovia D; Abud-Mendoza C
    Clin Exp Immunol; 1985 Apr; 60(1):31-8. PubMed ID: 3159524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).
    Ernst M; Kern P; Flad HD; Ulmer AJ
    J Clin Immunol; 1986 Mar; 6(2):170-81. PubMed ID: 2940258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor therapy in ataxia--telangiectasia.
    Berkel AI; Ersoy F; Epstein LB; Spitler LE
    Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of transfer factor in a pediatric AIDS patient with disseminated Mycobacterium avium intracellulare.
    Perrick D; Wray BB; Guill MF; Leffell MS; Lobel SA
    Ann Allergy; 1989 May; 62(5):437-40. PubMed ID: 2719353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of AIDS with transfer factor.
    Carey JT; Lederman MM
    JAMA; 1987 Dec; 258(24):3515-6. PubMed ID: 3682152
    [No Abstract]   [Full Text] [Related]  

  • 8. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
    J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 and interleukin 2 production in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex.
    Gupta S; Vayuvegula B; Ruhling M; Thornton M
    J Clin Lab Immunol; 1987 Mar; 22(3):113-6. PubMed ID: 3112400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of interleukin-2 in patients with acquired immunodeficiency syndrome.
    Lane HC; Siegel JP; Rook AH; Masur H; Gelmann EP; Quinnan GV; Fauci AS
    J Biol Response Mod; 1984 Oct; 3(5):512-6. PubMed ID: 6334138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report on three AIDS Patients treated with anti-HIV specific transfer factor.
    Viza D; Lefesvre A; Patrasco M; Phillips J; Hebbrecht N; Laumond G; Vich JM
    J Exp Pathol; 1987; 3(4):653-9. PubMed ID: 3454809
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
    Vadhan-Raj S; Wong G; Gnecco C; Cunningham-Rundles S; Krim M; Real FX; Oettgen HF; Krown SE
    Cancer Res; 1986 Jan; 46(1):417-25. PubMed ID: 2415251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological response modifiers. Interferons, interleukins, and transfer factor.
    Kirkpatrick CH
    Ann Allergy; 1989 Mar; 62(3):170-6. PubMed ID: 2466425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo controlled clinical trial of transfer factor in lepromatous leprosy.
    Faber WR; Leiker DL; Nengerman IM; Schellekens PT
    Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.